Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Kaleido Biosciences Inc

KLDO
Current price
0.0001 USD 0 USD (0.00%)
Last closed 0.0001 USD
ISIN US4833471000
Sector Healthcare
Industry Biotechnology
Exchange PINK
Capitalization 4 262 USD
Yield for 12 month 0.00 %
1Y
3Y
5Y
10Y
15Y
KLDO
21.11.2021 - 28.11.2021

Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the treatment of multi drug resistant infection, chronic kidney disease, atherosclerotic cardiovascular disease, cardio-metabolic syndrome, immuno-oncology, and inflammatory bowel diseases. The company has collaboration agreements with Institute Gustave Roussy, Washington University, and Janssen. Kaleido Biosciences, Inc. was incorporated in 2015 and is headquartered in Lexington, Massachusetts. Address: 65 Hayden Avenue, Lexington, MA, United States, 02421

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

22 USD

P/E ratio

Dividend Yield

Current Year

Last Year

+1 104 000 USD

Current Quarter

Last Quarter

Current Year

Last Year

-1 254 000 USD

Current Quarter

Last Quarter

Key Figures KLDO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -85 164 000 USD
Operating Margin TTM -3974.39 %
PE Ratio
Return On Assets TTM -99.93 %
PEG Ratio
Return On Equity TTM -580.57 %
Wall Street Target Price 22 USD
Revenue TTM 1 104 000 USD
Book Value 0.25 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 102.5 %
Dividend Yield
Gross Profit TTM -66 699 000 USD
Earnings per share -2.16 USD
Diluted Eps TTM -2.16 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics KLDO

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History KLDO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation KLDO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 27.3723
Price Sales TTM 0.0039
Enterprise Value EBITDA 0.1971
Price Book MRQ 0.0008

Financials KLDO

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators KLDO

For 52 weeks

0.0005 USD
50 Day MA 0.0001 USD
Shares Short Prior Month 2 331 117
200 Day MA 0.0001 USD
Short Ratio 29.34
Shares Short 2 339 422
Short Percent 14.19 %